Health condition monitoring solution under the limelight

Infomining is a solution company that researches and develops biorhythm through artificial intelligence. The company has commercialized products that can manage high blood pressure, electrocardiogram and blood sugar through smart-watches that have developed biorhythm, and have already been delivered to the Korea Centers for Disease Control and Prevention and are currently in use. In addition, systems for controlling and managing the entry and exit of major international airports in Korea are also under development and installation in recognition of these excellent development capabilities and research. 

Infomining (CEO: Jae-yong Lee) is also being asked to cooperate with 25 researchers from SKT and KT, the largest telecommunication companies, and is currently participating in development of the service sector. When it was introduced to related companies through Elematec in Japan, about 6-7 large companies were interested in using R&D requests and solutions. 

Currently, the Corona crisis is undergoing new conditions for each country. Although countries are paying attention to vaccinations, they continue to mutate due to the nature of the virus. Due to the prolonged corona crisis, our daily lives and environment has changed and been restricted. Perhaps that’s why many companies have been studying solutions that can check individual health conditions and connect with specialists for a long time, and it seems that it’s time for individuals to take care of our health because they’re showing limitations in the medical system. The company’s solutions introduced above can certainly help us manage our daily lives and healthy lives. Not only does the smart-watch developed by large companies provide more diverse and accurate data, but it is also being used in large hospitals or professional medical demonstrations to provide systematic management through connection with professional medical personnel.

Although small and medium-sized R&D companies are still struggling with the production and continuous development costs of device watches, it is expected that they will help our daily lives as many large companies are already interested in investing and linking. Global pharmaceutical companies in Korea and Japanese global companies are expected to link large-scale investment and cooperation within the first half of the year.

Sam Kim 

Asia Journal

▲ INFOMINING CO., LTD

▲ CEO : Jae-yong Lee

▲ http://infomining.co.kr 

▲ worldconsult@infomining.co.kr

▲ +82-70-4914-2970

spot_img

Latest Articles